Cargando…

Correction to ‘Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation’

Detalles Bibliográficos
Autores principales:	Gaughan, Luke, Logan, Ian R, Neal, David E, Robson, Craig N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464052/ https://www.ncbi.nlm.nih.gov/pubmed/34469575 http://dx.doi.org/10.1093/nar/gkab741

Ejemplares similares

Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
por: Gaughan, Luke, et al.
Publicado: (2005)

Regulation of the androgen receptor by SET9-mediated methylation
por: Gaughan, Luke, et al.
Publicado: (2013)

Corrigendum to “Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats”
por: Zhou, Jing, et al.
Publicado: (2021)

The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells
por: Kemp, Michael G., et al.
Publicado: (2005)

Correction to ‘BAP18 coactivates androgen receptor action and promotes prostate cancer progression’
por: Sun, Shiying, et al.
Publicado: (2021)

Regulation of the androgen receptor by SET9-mediated methylation
por: Gaughan, Luke, et al.
Publicado: (2011)

INHIBITION OF ANDROGEN RECEPTOR ACTIVITY BY HISTONE DEACETYLASE 4 THROUGH RECEPTOR SUMOYLATION
por: Yang, Yonghua, et al.
Publicado: (2011)

The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80
por: Typas, Dimitris, et al.
Publicado: (2016)

Decoding histone ubiquitylation
por: Chen, Jennifer J., et al.
Publicado: (2022)

Differential regulation of the androgen receptor by protein phosphatase regulatory subunits
por: Grey, James, et al.
Publicado: (2017)

Deubiquitinating enzyme Usp12 regulates the interaction between the androgen receptor and the Akt pathway
por: McClurg, Urszula L., et al.
Publicado: (2014)

Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation
por: Liu, Xiaming, et al.
Publicado: (2015)

[Corrigendum] Effects of histone deacetylase inhibitors on ATP‑binding cassette transporters in lung cancer A549 and colorectal cancer HCT116 cells
por: Wang, Hao, et al.
Publicado: (2023)

FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer
por: Jones, Dominic, et al.
Publicado: (2015)

Nutlin-3 inhibits androgen receptor-driven c-FLIP expression, resulting in apoptosis of prostate cancer cells
por: Logan, Ian R., et al.
Publicado: (2016)

Corrigendum to ‘The long and the short of it: the MDM4 tail so far’
por: Haupt, Sue, et al.
Publicado: (2019)

The Impact of Androgen Receptor and Histone Deacetylase 1 Expression on the Prognosis of Ductal Carcinoma In Situ
por: Lee, Choong Man, et al.
Publicado: (2020)

Corrigendum to: The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
Publicado: (2020)

MicroRNA‐205 is associated with diabetes mellitus‐induced erectile dysfunction via down‐regulating the androgen receptor
Publicado: (2023)

Cytostatic Action of Novel Histone Deacetylase Inhibitors in Androgen Receptor-Null Prostate Cancer Cells
por: Rana, Zohaib, et al.
Publicado: (2021)

Corrigendum to “Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer” (EBioMedicine Aug 2016; 10: 124–36)
por: Wei, Tzu-Tang
Publicado: (2017)

Histone levels are regulated by phosphorylation and ubiquitylation dependent proteolysis
por: Singh, Rakesh Kumar, et al.
Publicado: (2009)

The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer
por: Wade, Mark A., et al.
Publicado: (2015)

MAGE-A Cancer/Testis Antigens Inhibit MDM2 Ubiquitylation Function and Promote Increased Levels of MDM4
por: Marcar, Lynnette, et al.
Publicado: (2015)

Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma
Publicado: (2023)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma
por: Seligson, Nathan D., et al.
Publicado: (2019)

Corrigendum to “The Study of MDM2 rs937283 Variantand Cancer Susceptibility in a Central Chinese Population”
Publicado: (2020)

Alterations in gene expression during sexual differentiation in androgen receptor knockout mice induced by environmental endocrine disruptors
por: Liu, Dehong, et al.
Publicado: (2019)

RNF8 mediates histone H3 ubiquitylation and promotes glycolysis and tumorigenesis
por: Xia, Yan, et al.
Publicado: (2017)

Correction to ‘Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes’
por: Pasini, Diego, et al.
Publicado: (2021)

Corrigendum to ‘New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells’
por: Lee, Soo Ok, et al.
Publicado: (2020)

HepaCAM inhibits cell proliferation and invasion in prostate cancer by suppressing nuclear translocation of the androgen receptor via its cytoplasmic domain
por: Deng, Qingfu, et al.
Publicado: (2022)

BMI1-mediated histone ubiquitylation promotes DNA double-strand break repair
por: Ismail, Ismail Hassan, et al.
Publicado: (2010)

Combination of phospholipase Cε knockdown with GANT61 sensitizes castration-resistant prostate cancer cells to enzalutamide by suppressing the androgen receptor signaling pathway
por: Sun, Wei, et al.
Publicado: (2022)

Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression
por: Ito, Kazuhiro, et al.
Publicado: (2006)

MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2
por: Wu, Deyao, et al.
Publicado: (2022)

Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2–p53 signaling
por: Xie, Chuhai, et al.
Publicado: (2016)

Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer
por: Alzoubi, Samer, et al.
Publicado: (2016)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vplj2ecis3dr66tb3rdav6p7lk